These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 10359669

  • 1. Copper(II)-induced self-oligomerization of alpha-synuclein.
    Paik SR, Shin HJ, Lee JH, Chang CS, Kim J.
    Biochem J; 1999 Jun 15; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
    [Abstract] [Full Text] [Related]

  • 2. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
    Paik SR, Shin HJ, Lee JH.
    Arch Biochem Biophys; 2000 Jun 15; 378(2):269-77. PubMed ID: 10860544
    [Abstract] [Full Text] [Related]

  • 3. Comparisons of the NACP self-oligomerizations induced by Abeta25-35 in the presence of dicyclohexylcarbodiimide and N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline.
    Lee JH, Shin HJ, Chang CS, Paik SR.
    Neurochem Res; 1998 Nov 15; 23(11):1427-34. PubMed ID: 9814554
    [Abstract] [Full Text] [Related]

  • 4. Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2.
    Lee EN, Lee SY, Lee D, Kim J, Paik SR.
    J Neurochem; 2003 Mar 15; 84(5):1128-42. PubMed ID: 12603836
    [Abstract] [Full Text] [Related]

  • 5. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
    Tabner BJ, Turnbull S, El-Agnaf OM, Allsop D.
    Free Radic Biol Med; 2002 Jun 01; 32(11):1076-83. PubMed ID: 12031892
    [Abstract] [Full Text] [Related]

  • 6. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA, Harper JD, Lansbury PT.
    Biochemistry; 2000 Mar 14; 39(10):2552-63. PubMed ID: 10704204
    [Abstract] [Full Text] [Related]

  • 7. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M, Rockenstein E, Crews L, Masliah E.
    Neuromolecular Med; 2003 Mar 14; 4(1-2):21-36. PubMed ID: 14528050
    [Abstract] [Full Text] [Related]

  • 8. Self-oligomerization and protein aggregation of alpha-synuclein in the presence of Coomassie Brilliant Blue.
    Lee D, Lee EK, Lee JH, Chang CS, Paik SR.
    Eur J Biochem; 2001 Jan 14; 268(2):295-301. PubMed ID: 11168363
    [Abstract] [Full Text] [Related]

  • 9. Self-oligomerization of NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25-35).
    Paik SR, Lee JH, Kim DH, Chang CS, Kim YS.
    FEBS Lett; 1998 Jan 02; 421(1):73-6. PubMed ID: 9462843
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro.
    Turnbull S, Tabner BJ, El-Agnaf OM, Moore S, Davies Y, Allsop D.
    Free Radic Biol Med; 2001 May 15; 30(10):1163-70. PubMed ID: 11369507
    [Abstract] [Full Text] [Related]

  • 15. Eosin interaction of alpha-synuclein leading to protein self-oligomerization.
    Shin HJ, Lee EK, Lee JH, Lee D, Chang CS, Kim YS, Paik SR.
    Biochim Biophys Acta; 2000 Aug 31; 1481(1):139-46. PubMed ID: 11004584
    [Abstract] [Full Text] [Related]

  • 16. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
    Krüger R, Müller T, Riess O.
    J Neural Transm (Vienna); 2000 Aug 31; 107(1):31-40. PubMed ID: 10809401
    [Abstract] [Full Text] [Related]

  • 17. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
    Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Sisk A, Masliah E.
    Lab Invest; 1998 Sep 31; 78(9):1169-77. PubMed ID: 9759660
    [Abstract] [Full Text] [Related]

  • 18. Forcing nonamyloidogenic beta-synuclein to fibrillate.
    Yamin G, Munishkina LA, Karymov MA, Lyubchenko YL, Uversky VN, Fink AL.
    Biochemistry; 2005 Jun 28; 44(25):9096-107. PubMed ID: 15966733
    [Abstract] [Full Text] [Related]

  • 19. Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide.
    Jensen PH, Sørensen ES, Petersen TE, Gliemann J, Rasmussen LK.
    Biochem J; 1995 Aug 15; 310 ( Pt 1)(Pt 1):91-4. PubMed ID: 7646476
    [Abstract] [Full Text] [Related]

  • 20. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
    Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L.
    Proc Natl Acad Sci U S A; 2001 Oct 09; 98(21):12245-50. PubMed ID: 11572944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.